According to a study by Francesco Sclafani et al., somatic mutations in the KRAS, NRAS, BRAF, PIK3CA, and TP53 genes are encountered in 43%, 9%, 4%, 9%, and 60% of rectal cancer cases, respectively [67]. The gene discussed is TP53; the disease is rectal cancer.